Treatment with Kadcyla 160mg Injection

Active ingredient: Ado-Trastuzumab emtansine

Uses:

• Advanced and metastatic breast cancer
• Metastatic gastric cancer

Mechanism of action:

• Kadcyla combines the targeting ability of trastuzumab, which binds to HER2-positive cancer cells, with the cell-killing effects of emtansine, a chemotherapy drug.
• Once the medication binds to the HER2-positive cancer cells, it releases emtansine, which then enters the cancer cells and destroys them.

Administration:

• Kadcyla 160mg Injection is administered by a healthcare professional in a hospital or clinic setting.
• The dose and frequency depend on several factors, such as the individual's age, weight, overall health, and the type and stage of the cancer being treated.

Safety advice:

• Discuss with your physician before taking this medication if you are pregnant or think you might be pregnant.
• Avoid breastfeeding your baby while on the treatment with Kadcyla 160mg Injection for at least seven months after the final dose.
• Patients with pre-existing lung conditions should consult a doctor before taking it.
• Inform your healthcare professional if you have any history of liver problems, such as hepatitis or cirrhosis, before starting treatment.
• Avoid consuming alcohol while taking Ado-Trastuzumab Emtansine.
• Avoid driving or handling machinery during the treatment.

Side effects:

• Serious: infusion reactions, lung problems, heart problems, severe bleeding or bruising, nerve damage, severe allergic reactions.
• Common: fatigue, nausea, constipation, muscle or joint pain, headache, fever, low platelet count, high liver enzyme levels, low red blood cell count, loss of appetite, rash or itching.

FAQs:

1. Can Kadcyla 160mg Injection cause nerve damage? Kadcyla 160mg Injection can cause peripheral neuropathy, a type of nerve damage that can cause tingling, numbness, or weakness in the hands and feet.

2. Does Kadcyla 160mg Injection cause infertility? Kadcyla 160mg Injection can cause temporary infertility in some patients, particularly women.

3. How is Kadcyla 160mg Injection different from traditional chemotherapy? Ado-Trastuzumab Emtansine is a type of chemotherapy, but it is designed to target HER2-positive cancer cells specifically, which may result in fewer side effects than traditional chemotherapy.

4. Can Kadcyla 160mg Injection be used in combination with other cancer treatments? Kadcyla 160mg Injection may be used in combination with other cancer treatments, such as chemotherapy or targeted therapies.

5. Can I take ado-trastuzumab emtansine if I have tuberculosis? The use of ado-trastuzumab emtansine (Kadcyla 160mg Injection) in patients with active tuberculosis (TB) is not recommended due to the risk of worsening the TB infection.

6. Can Kadcyla 160mg Injection cause heart problems? Kadcyla 160mg Injection can cause heart problems, particularly in patients with preexisting heart conditions or risk factors.

Fact box:

• Molecule name: Trastuzumab
• Therapeutic class: Anti-cancer
• Pharmacological class: HER2 inhibitor

Теги: cancer_treatment, chemotherapy, drug_injection, kadcyla, breast_cancer_treatment